IBM jumps into genome sequencing with nanopore chip

DNA sequencing is a broadly enabling technology, guiding research and applications as disparate as pharmaceuticals, food and nutrition, and biofuels. IBM has just announced that it will be entering the growing and hotly competitive space, with a nanopore-riddled silicon chip: Each of the chip's pore...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

FDA authorizes emergency use of Lucira's at-home test kit – with results in 30 minutes and no shipping to a lab

News Commentary | November 25, 2020

This advancement in POC testing is one that decentralizes the testing process and allows for nearly immediate self‑quarantine and thereby reducing the burden on shipping and laboratory infrastructure. While clients may want to take note of this development for use for their own employees, clients ... To read more, click here.

Oxford Nanopore prepares for a $3 billion IPO

News Commentary | April 01, 2021

Oxford Nanopore's nanopore technology has come into the limelight since the COVID‑19 outbreak. Since then, it has supported scientists in over 85 countries in tracking the emergence of new mutant variants. This field validation and its ability to overcome various technical hurdles sets the stage for... To read more, click here.

Helix's pivot from consumer genomics to population genomics highlights broader shifts in the human genomics landscape

Case Study | July 29, 2021

Helix Genomics came into the spotlight a few years ago when it pioneered a digital marketplace concept for genomics where it used a dynamic consent model to allow third‑party developers to turn genomics data into personalized insights for the consumer. It also offered whole‑exome sequencing (WES), ... Not part of subscription